DK0750669T3 - Modificeret papillomavirus-L2-protein og VLP'er dannet derudfra - Google Patents

Modificeret papillomavirus-L2-protein og VLP'er dannet derudfra

Info

Publication number
DK0750669T3
DK0750669T3 DK95907507T DK95907507T DK0750669T3 DK 0750669 T3 DK0750669 T3 DK 0750669T3 DK 95907507 T DK95907507 T DK 95907507T DK 95907507 T DK95907507 T DK 95907507T DK 0750669 T3 DK0750669 T3 DK 0750669T3
Authority
DK
Denmark
Prior art keywords
protein
formed therefrom
modified
virus
vlps formed
Prior art date
Application number
DK95907507T
Other languages
English (en)
Inventor
Ian Frazer
Jian Zhou
Original Assignee
Univ Queensland
Csl Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Queensland, Csl Ltd filed Critical Univ Queensland
Application granted granted Critical
Publication of DK0750669T3 publication Critical patent/DK0750669T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20023—Virus like particles [VLP]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK95907507T 1994-01-31 1995-01-31 Modificeret papillomavirus-L2-protein og VLP'er dannet derudfra DK0750669T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPM3588A AUPM358894A0 (en) 1994-01-31 1994-01-31 Modified papilloma virus l2 protein and vlps formed therefrom
PCT/AU1995/000043 WO1995020659A1 (en) 1994-01-31 1995-01-31 MODIFIED PAPILLOMA VIRUS L2 PROTEIN AND VLPs FORMED THEREFROM

Publications (1)

Publication Number Publication Date
DK0750669T3 true DK0750669T3 (da) 2003-02-24

Family

ID=3778209

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95907507T DK0750669T3 (da) 1994-01-31 1995-01-31 Modificeret papillomavirus-L2-protein og VLP'er dannet derudfra

Country Status (12)

Country Link
US (1) US5993821A (da)
EP (1) EP0750669B1 (da)
JP (1) JP3417948B2 (da)
KR (1) KR100353762B1 (da)
AT (1) ATE226253T1 (da)
AU (1) AUPM358894A0 (da)
DE (1) DE69528578T2 (da)
DK (1) DK0750669T3 (da)
ES (1) ES2187551T3 (da)
NZ (1) NZ279166A (da)
SG (1) SG47362A1 (da)
WO (1) WO1995020659A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
GB9806666D0 (en) * 1998-03-27 1998-05-27 Stanley Margaret Antigen preparation and use
US7439016B1 (en) * 2000-06-15 2008-10-21 Digene Corporation Detection of nucleic acids by type-specific hybrid capture method
AUPR446801A0 (en) 2001-04-18 2001-05-17 University Of Queensland, The Novel compositions and uses therefor
US8877436B2 (en) * 2008-10-27 2014-11-04 Qiagen Gaithersburg, Inc. Fast results hybrid capture assay on an automated platform
EP2470554B1 (en) * 2009-08-26 2017-06-28 Selecta Biosciences, Inc. Compositions that induce t cell help
US9376727B2 (en) 2010-05-25 2016-06-28 Qiagen Gaithersburg, Inc. Fast results hybrid capture assay and associated strategically truncated probes
CN113075992B (zh) * 2021-04-13 2022-07-05 浪潮电子信息产业股份有限公司 一种内存上电方法、装置、设备及计算机可读存储介质

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2641081A1 (da) * 1988-12-23 1990-06-29 Medgenix Group
GB9113809D0 (en) * 1991-06-26 1991-08-14 Cancer Res Campaign Tech Papillomavirus l2 protein
DE122007000017I1 (de) * 1991-07-19 2007-07-26 Univ Queensland Impfstoffe gegen Papillomavirus
EP1588713B1 (en) * 1993-03-09 2010-12-22 The University Of Rochester Production of human papillomavirus HBV-11 capsid protein L1 and virus-like particles
GB9306731D0 (en) * 1993-03-31 1993-05-26 Cancer Res Campaign Tech Vaccines

Also Published As

Publication number Publication date
DE69528578D1 (de) 2002-11-21
EP0750669A1 (en) 1997-01-02
DE69528578T2 (de) 2003-07-17
WO1995020659A1 (en) 1995-08-03
US5993821A (en) 1999-11-30
JP3417948B2 (ja) 2003-06-16
ES2187551T3 (es) 2003-06-16
AUPM358894A0 (en) 1994-02-24
EP0750669A4 (en) 1998-05-27
ATE226253T1 (de) 2002-11-15
JPH09508273A (ja) 1997-08-26
NZ279166A (en) 1997-11-24
KR100353762B1 (ko) 2002-12-26
EP0750669B1 (en) 2002-10-16
SG47362A1 (en) 1998-04-17

Similar Documents

Publication Publication Date Title
DE122011100018I1 (de) Herstellung von menschlichem Papilloma-Virus-Capsid-Protein und virusahnlichen Teilchen.
NL300323I1 (nl) Op papillomavirus lijkende deeltjes, fusie-eiwitten alsook werkwijze
DE69535018D1 (de) Papillomavirus vakzine
WO2003078455A3 (en) Virus like particle from papillomavirus and their use in vaccine
AP1872A (en) Virus-like particles of human papillomavirus.
DE69835294D1 (de) Methode zur in vitro auseinander- und wiederzusammensetzung von papillomavirus virus-ähnlichen tielchen (vlps)
DK0750669T3 (da) Modificeret papillomavirus-L2-protein og VLP'er dannet derudfra
CA2182272A1 (en) Modified papilloma virus l2 protein and vlps formed therefrom